{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:06Z","timestamp":1792425726275,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>AIMS<\/jats:p>\n                    <jats:p>Myasthenia Gravis (MG) is an autoimmune neuromuscular disease in which patients suffer from recurrent exacerbation. There are insufficient data measuring the effects of the resources employed before and during acute exacerbation on subsequent disease outcomes. This study aims to identify factors which lead to lengthened hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective chart review of acute MG exacerbations requiring hospitalization. Exacerbations were identified using ICD-9\/ICD-10 codes and considered the following variables: age and Myasthenia Gravis Foundation of America (MGFA) class at initial MG diagnosis, age and MGFA class at exacerbation, sex, thymectomy, cause of exacerbation, treatment regimen at time of exacerbation, inpatient treatment regimen, length of hospital stay (LOS), intubation, use of noninvasive ventilation, complications, and disposition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy patients with 141 hospitalizations were identified. Crisis management characterized by intubation and plasmapheresis positively correlated with LOS (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001). Almost 1\/5 hospitalizations required intubation. Previous thymectomy negatively correlated with LOS\n                      <jats:italic>(p<\/jats:italic>\n                      \u2009&lt;\u2009.05). In contrast, male sex correlated with longer LOS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.05). One-third of hospital stays were followed by discharge to a post-acute care facility, 7% home with home health, and 1 hospitalization resulted in death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Plasmapheresis, intubation, and male sex were associated with increased LOS in acute MG exacerbation. Intubation appears to be the strongest predictor of LOS. Those with previous thymectomy had shorter hospital stays. The role of thymectomy in the acute setting merits further analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-022-02922-9","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T23:29:19Z","timestamp":1673479759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of length of stay and treatment emergent complications in hospitalized myasthenia gravis patients with exacerbation"],"prefix":"10.1186","volume":"23","author":[{"given":"Taylor","family":"Ramsaroop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Gelinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ah","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"2922_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/mus.26689","volume":"60","author":"RR Gummi","year":"2019","unstructured":"Gummi RR, Kukulka NA, Deroche CB, Govindarajan R. Factors associated with acute exacerbations of myasthenia gravis. Muscle Nerve. 2019;60:693\u20139. https:\/\/doi.org\/10.1002\/mus.26689.","journal-title":"Muscle Nerve"},{"issue":"4","key":"2922_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CND.0000000000000034","volume":"15","author":"Treatment-refractory myasthenia gravis","year":"2014","unstructured":"Treatment-refractory myasthenia gravis. Silvestri NJ, Wolfe GI. J Clin Neuromuscul Dis. 2014;15(4):167.","journal-title":"J Clin Neuromuscul Dis"},{"key":"2922_CR3","doi-asserted-by":"publisher","first-page":"175628561774913","DOI":"10.1177\/1756285617749134","volume":"11","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza R, Antozzi C. When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Ther Adv Neurol Disord. 2018;11:1756285617749134 (Epub 2018 Jan 18).","journal-title":"Ther Adv Neurol Disord"},{"key":"2922_CR4","doi-asserted-by":"crossref","unstructured":"Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist. 2011;1(1):16.","DOI":"10.1177\/1941875210382918"},{"issue":"5","key":"2922_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","volume":"48","author":"CE Thomas","year":"1997","unstructured":"Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, Brannagan TH, Fink ME, Rowland LP. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997;48(5):1253.","journal-title":"Neurology"},{"issue":"7","key":"2922_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/13696998.2019.1592180","volume":"22","author":"L Harris","year":"2019","unstructured":"Harris L, Graham S, MacLachlan S, Exuzides A, Jacob S. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691\u20137. https:\/\/doi.org\/10.1080\/13696998.2019.1592180.","journal-title":"J Med Econ"},{"issue":"4","key":"2922_CR7","first-page":"286","volume":"19","author":"S Tiamkao","year":"2014","unstructured":"Tiamkao S, et al. Prevalence of factors associated with poor outcomes of hospitalized myasthenia gravis patients in Thailand. Neurosciences (Riyadh, Saudi Arabia). 2014;19(4):286\u201390.","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"key":"2922_CR8","doi-asserted-by":"publisher","unstructured":"Tiamkao, Somsak et al. \u201cFactors predicting the outcomes of elderly hospitalized myasthenia gravis patients: a national database study.\u201d International journal of general medicine vol. 10 131\u2013135. 20 Apr. 2017, doi:https:\/\/doi.org\/10.2147\/IJGM.S129075","DOI":"10.2147\/IJGM.S129075"},{"key":"2922_CR9","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.118.3.392","author":"W Gardner","year":"1995","unstructured":"Gardner W, Mulvey EP, Shaw EC. Regression Analyses of Counts and Rates: Poisson, Overdispersed Poisson, and Negative Binomial Models. Psychol Bull. 1995. https:\/\/doi.org\/10.1037\/0033-2909.118.3.392.","journal-title":"Psychol Bull"},{"key":"2922_CR10","doi-asserted-by":"publisher","unstructured":"Hilbe JM. Modeling Count Data.; 2014. doi:https:\/\/doi.org\/10.1007\/978-3-642-04898-2_369","DOI":"10.1007\/978-3-642-04898-2_369"},{"key":"2922_CR11","doi-asserted-by":"publisher","unstructured":"Zuur AF, Ieno EN, Walker NJ, Saveliev AA. Zero-truncated and zero-inflated models for count data. Mixed effects models and extensions in ecology with R. Springer. 2009.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B. 1995. doi:https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141\u2013149.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"2922_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4103\/0028-3886.144438","volume":"62","author":"SV Khadilkar","year":"2014","unstructured":"Khadilkar SV, Chaudhari CR, Patil TR, Desai ND, Jagiasi KA, Bhutada AG. Once myasthenic, always myasthenic? Observations on\/ the behavior and prognosis of myasthenia gravis in a cohort of 100 patients. Neurol India. 2014;62:492\u20137.","journal-title":"Neurol India"},{"key":"2922_CR13","unstructured":"Role of Thymectomy in Patients with Myasthenia Gravis. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed Dec 2021.) https:\/\/www.uptodate.com\/contents\/role-of-thymectomy-in-patients-with-myasthenia-gravis"},{"key":"2922_CR14","doi-asserted-by":"publisher","unstructured":"Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;375(26):2570\u201381. https:\/\/doi.org\/10.1056\/NEJMra1602678.","DOI":"10.1056\/NEJMra1602678"},{"issue":"6","key":"2922_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"Randomized Trial of Thymectomy in Myasthenia Gravis","year":"2016","unstructured":"Randomized Trial of Thymectomy in Myasthenia Gravis. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Str\u00f6bel P, et al. N Engl J Med. 2016;375(6):511.","journal-title":"N Engl J Med"},{"issue":"1","key":"2922_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1212\/WNL.55.1.7","volume":"55","author":"GS Gronseth","year":"2000","unstructured":"Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(1):7 (American Academy of Neurology, St. Paul, MN 55116, USA).","journal-title":"Neurology"},{"key":"2922_CR17","unstructured":"Overview of the Treatment of Myasthenia Gravis. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed December 2020.) https:\/\/www.uptodate.com\/contents\/overview-of-the-treatment-of-myasthenia-gravis"},{"key":"2922_CR18","unstructured":"Clinical Manifestations of Myasthenia Gravis. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed December 2020.) https:\/\/www.uptodate.com\/contents\/clinical-manifestations-of-myasthenia-gravis"},{"key":"2922_CR19","doi-asserted-by":"publisher","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Str\u00f6bel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016 Aug 11;375(6):511\u201322. doi: https:\/\/doi.org\/10.1056\/NEJMoa1602489. Erratum in: N Engl J Med. 2017 May 25;376(21):2097. [Dosage error in article text]. PMID: 27509100; PMCID: PMC5189669.","DOI":"10.1056\/NEJMoa1602489"},{"key":"2922_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1196\/annals.1405.021","volume":"1132","author":"N Willcox","year":"2008","unstructured":"Willcox N, Leite MI, Kadota Y, Jones M, Meager A, Subrahmanyam P, Dasgupta B, Morgan BP, Vincent A. Autoimmunizing mechanisms in thymoma and thymus. Ann N Y Acad Sci. 2008;1132:163\u201373. https:\/\/doi.org\/10.1196\/annals.1405.021 (PMID: 18567866).","journal-title":"Ann N Y Acad Sci"},{"key":"2922_CR21","doi-asserted-by":"publisher","unstructured":"K\u00f6nig N, Stetefeld HR, Dohmen C, Mergenthaler P, Kohler S, Sch\u00f6nenberger S, B\u00f6sel J, Lee DH, Gerner ST, Huttner HB, Schneider H, Reichmann H, Fuhrer H, Berger B, Zinke J, Alberty A, Kleiter I, Schneider-Gold C, Roth C, Dunkel J, Steinbrecher A, Thieme A, Schlachetzki F, Linker RA, Angstwurm K, Meisel A, Neumann B; German Myasthenic Crisis Study Group. MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation. J Neurol. 2021 Dec;268(12):4824\u20134833. doi: https:\/\/doi.org\/10.1007\/s00415-021-10603-9. Epub 2021 May 10. PMID: 33970337; PMCID: PMC8563593.","DOI":"10.1007\/s00415-021-10603-9"},{"key":"2922_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.nmd.2007.07.002","volume":"17","author":"JM Heckmann","year":"2007","unstructured":"Heckmann JM, Owen EP, Little F. Myasthenia Gravis in South Africans: Racial Differences in Clinical Manifestations. Neuromuscul Disord. 2007;17:929\u201334.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"2922_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4.PMID:35413850;PMCID:PMC9005160","volume":"19","author":"C Nelke","year":"2022","unstructured":"Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N, Mergenthaler P, Arat E, \u00d6zt\u00fcrk M, Foell D, Schreiber S, Vielhaber S, Gassa A, Stetefeld H, Schroeter M, Berger B, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Wiendl H, Ruck T. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J Neuroinflammation. 2022;19(1):89. https:\/\/doi.org\/10.1186\/s12974-022-02448-4.PMID:35413850;PMCID:PMC9005160.","journal-title":"J Neuroinflammation"},{"key":"2922_CR24","doi-asserted-by":"publisher","unstructured":"Neumann B, Angstwurm K, Mergenthaler P, Kohler S, Sch\u00f6nenberger S, B\u00f6sel J, Neumann U, Vidal A, Huttner HB, Gerner ST, Thieme A, Steinbrecher A, Dunkel J, Roth C, Schneider H, Schimmel E, Fuhrer H, Fahrendorf C, Alberty A, Zinke J, Meisel A, Dohmen C, Stetefeld HR; German Myasthenic Crisis Study Group. Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases. Neurology. 2020 Jan 21;94(3):e299-e313. doi: https:\/\/doi.org\/10.1212\/WNL.0000000000008688. Epub 2019 Dec 4. Erratum in: Neurology. 2020 Apr 21;94(16):724. Schneider, Haucke [corrected to Schneider, Hauke]. PMID: 31801833.","DOI":"10.1212\/WNL.0000000000008688"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02922-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02922-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02922-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T23:29:43Z","timestamp":1673479783000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02922-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2922"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02922-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1785699\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There was no experimenting on humans or use of human tissue samples involved in this study. This study was ethically conducted with approval by the University of Missouri Campus Institutional Review Board. Informed consent from subjects was waived per IRB approval as this study was considered to pose minimal risk and all personal identifying information was de-identified. All methods were carried out in accordance with relevant guidelines and regulations. Further information and documentation to support this can be made available upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}